Crunch Time For Idorsia Insomnia Therapy As Reviews Begin
Daridorexant Is Swiss Company's First Drug
The US FDA has accepted the Swiss biotech's "huge" NDA file for daridorexant which the company hopes will be more successful on the insomnia market than other DORA sleep treatments such as Merck & Co's Belsomra.